Manufacturing proficiency has been Lincoln Pharma’s forte ever since its inception. We have ensured world-class quality in design, equipment and operations in our manufacturing facilities. Our units ensure that we are able to provide best-in-class products to patients to more than 60 countries worldwide.
Company develops and manufactures affordable and innovative medicines for healthier lives for more than 60 countries worldwide
Set up in the year 1979, Lincoln Pharma has a state-of-the-art manufacturing facilities at Khatraj in Ahmedabad, Gujarat, complying with stringent international quality and compliance norms and certified by WHO-GMP and ISO-9001: 2015. Company is engaged in manufacturing of pharma formulations like Tablets, Capsules, Injectable, Dry Syrup, Liquid Oral, Sprinkling Powder, Sterile and General Ointments, etc.
The company has developed 300 plus formulations in 15 therapeutic areas
We also have a strong product/brand portfolio in anti-infective, respiratory system, gynaecology, cardio & CNS, anti-bacterial, anti-diabetic, anti-malaria and among others. The company markets its products in the Indian market and also exports to more than 60 Countries.
Besides continuously improving its market presence and market share, the group has also expanded its portfolio by entering newer therapeutic areas. The group has been launching new products with the first mover advantage and has a strong presence in both acute and chronic therapies.
Our manufacturing operations are focused on producing generics, branded generics, specialty, over-the-counter (OTC) products in the full range of dosage forms, including tablets, capsules, injectables, ointments, creams and liquids.
Our dedicated manufacturing team of more than 500 people ensures highest standards of operation with strong oversight from the quality team. Company has highly skilled team of regulatory affairs specialists who are well versed with regulatory policies and procedures around the world. Our experienced team has wealth of experience in the timely filing of dossiers as well as handling regulatory queries from both authorities and customers.
Production Capacity
Capacity to produce more than 2.5 billion diverse Dosage Forms annually at its two plants
Dosage Forms Produced at Unit 1
Dosage Forms Produced at Unit 2
Dosage Forms Produced at Unit 3 OSD and Dry Powder Injection